Norges Bank’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,508
Closed -$992K 642
2025
Q4
$992K Buy
+26,508
New +$872K ﹤0.01% 1513
2025
Q3
Sell
-11,123
Closed -$351K 717
2025
Q2
$351K Sell
11,123
-42,927
-79% -$1.38M ﹤0.01% 1658
2025
Q1
$1.79M Sell
54,050
-414,360
-88% -$14.9M ﹤0.01% 1554
2024
Q4
$16.1M Buy
468,410
+64,791
+16% +$2.23M ﹤0.01% 1264
2024
Q3
$16.1M Buy
403,619
+275,631
+215% +$9.68M ﹤0.01% 1261
2024
Q2
$3.86M Sell
127,988
-37,767
-23% -$1.14M ﹤0.01% 1614
2024
Q1
$5.57M Sell
165,755
-11,803
-7% -$379K ﹤0.01% 1597
2023
Q4
$5.74M Sell
177,558
-12,770
-7% -$356K ﹤0.01% 1644
2023
Q3
$6.24M Hold
190,328
﹤0.01% 1630
2023
Q2
$6.7M Sell
190,328
-35,900
-16% -$1.24M ﹤0.01% 1647
2023
Q1
$7.39M Sell
226,228
-13,999
-6% -$638K ﹤0.01% 1666
2022
Q4
$13.2M Sell
240,227
-120,800
-33% -$6.64M ﹤0.01% 1460
2022
Q3
$16M Buy
+361,027
New +$17.6M ﹤0.01% 1324
2021
Q3
Sell
-72,800
Closed -$2.06M 2309
2021
Q2
$2.06M Buy
+72,800
New +$2.18M ﹤0.01% 2014

Other funds holding HRMY